Clinical Trial

Date Fruit Benefits to Treat Morning Sickness in First Trimester of Pregnancy

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated January 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized clinical trial is to evaluate role of date fruit in alleviating morning sickness of pregnancy in pregnant females. The main question\[s\] it aims to answer \[is/are\]: The goal of this randomized clinical trial is to evaluate role of date fruit in The goal of this randomized clinical trial is to evaluate role of date fruit in alleviating vomiting due to morning sickness of pregnancy and in improving maternal hemoglobin in pregnant females. The main question\[s\] it aims to answer \[are\]: * Role of date fruit in alleviating severity and frequency of vomiting due to morning sickness of pregnancy in pregnant females. * Role of date fruit in improving haemoglobin levels in pregnant females. * To assess improvement of severity and frequency of vomiting due to morning sickness of pregnancy and improvement of hemoglobin levels in pregnant females, researchers will compare date fruit intake with antiemetic medication doxylamine succinate 10 mg + pyridoxine HCl 10 and diet only.
Trial Details
NCT Number NCT07354529
Lead Sponsor Bahria University
Conditions Pregnancy
Enrollment 40 participants
Start Date 2025-06-15
Primary Completion 2026-01-25 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21